In the case of MLH1, reports have shown that MMR deficiency confers platinum resistance [53], whereas our results showed that down-regulation of MLH1 resulted in a significant increase in Olaparib sensitivity. The gene discussed is MLH1; the disease is hyperinsulinemic hypoglycemia, familial, 4.